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Abstract
Background: Porcine circovirus type 2 (PCV2), the causative agent of postweaning multisystemic wasting
syndrome (PMWS), is a serious economic problem in the swine industry. Different genotypes (PCV2a, PCV2b and
PCV2d) of the virus are present in the clinical cases in China, and it is necessary to elucidate the pathogenic
difference among different genotypes of PCV2. In this study, four strains of different genotypes were isolated, two
were ordinary strains and another two were mutation strains, which there are one and two amino acids elongation
in the capsid protein (Cap) of PCV2, respectively. Representative strains of different genotypes of the virus were
constructed by infectious molecular clone and biological characterization of the rescued viruses were identified in
vitro.
Results: Four PCV2 isolates (PCV2a/CL, PCV2b/YJ, PCV2b/JF and PCV2d/BDH) of different genotypes were isolated
from the clinical cases of PMWS in China. Four infectious clones of PCV2 were constructed and the rescued viruses
were harvested after transfection into PK15 cells. The rescued viruses were verified by nucleotide sequence analysis,
morphology of the viruses and immunoperoxidase monolayer assay (IPMA). The rescued viruses propagated stably
after consecutive incubation for more than ten passages, and virus propagation reached its peak 72h post infection
(PI), and the virus titers were up to 10
5.7 TCID50/ml. By using neutralizing 1D2 monoclonal antibody (mAb) of PCV2,
the antigen capture ELISA showed that only the PCV2a/rCL and PCV2b/rJF strains has immunoreactivity with the
1D2 mAb, however, another two rescued strains (PCV2b/rYJ and PCV2d/rBDH) do not, which indicated the
antigenic difference among the rescued viruses of different genotypes. In addition, here is the first report of
obtaining the newly emerging PCV2 with mutation in vitro by infectious molecular clone technology.
Conclusions: Conclusions drawn from this study show that PCV2 has prevailing differences in genomic and ORF2
gene length and antigen in swine herds in China. Four representative clones for different genotypes were
constructed and rescued, which will facilitate further studies on the pathogenic differences resulting from different
subtypes of PCV2.
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Porcine circovirus type 2 (PCV2) is a small non-
enveloped virus with a single-stranded circular DNA
genome of approximately 1.7 kb in size in the genus
Circovirus, family Circoviridae [1-4]. Its genome con-
tains at least two potentially functional open reading
frames (ORFs): ORF1 (945 bp) encodes the Rep pro-
tein involved in viral replication and ORF2 (702 bp)
encodes the immunogenic capsid protein [5-8]. PCV2
is generally considered to be the primary causative
agent of postweaning multisystemic wasting syndrome
(PMWS), which has become a serious economic pro-
blem for the swine industry worldwide. This disease
is first recognized in Canada in 1997, and then subse-
quently identified in pigs in the USA, France, Japan,
Korea and other countries [9-11]. Recently, a basic
unified nomenclature for PCV2 genotypes named as
PCV2a, PCV2b and PCV2c, proposed by the EU con-
sortium on porcine circovirus diseases http://www.
pcvd.net, facilitate the scientific communication and
studies [12]. Genetic variation among PCV2 prevailing
isolates has been reported by researchers worldwide
in recent years [13-21], and we have previously
demonstrated that some PCV2 with occurrence of
variation or mutation (a shift of ORF2 from 702 to
705 nt for PCV2d or 708 nt for PCV2b) were prevail-
ing in the field in China [7]. In this study, the aim
was to first rescue newly emerging porcine circovirus
type 2 with mutations as well as another two basic
genotypes strains (PCV2a and PCV2b), with an intro-
duction of tractable markers, respectively, by infec-
tious molecular clone techonology. Then, biological
characteristics of the four rescued PCV2 as represen-
tatives of different genotypes were identified in vitro,
which will facilitate the further studies on the differ-
ences in pathogenicity among different genotypes of
PCV2, especially the studies on the new emerging
PCV2 strains with mutation.
Materials and methods
Cells and viruses
A porcine kidney PK-15 cell line free of PCV1 contam-
ination that is highly permissive for PCV2 replication
was maintained in a minimum essential medium
(MEM) (Invitrogen, Grand Island, USA) supplemented
with 5% heat-inactivated fetal bovine serum (FBS)
(Invitrogen, Grand Island, USA) at 37°C under 5%
CO2. PCV2 was propagated in PK15 cells as previously
described [22]. Anti-PCV2-positive polyclonal swine
s e r aa n dP C V 2 - n e g a t i v es w i n es e r aw e r ep r e p a r e db y
our laboratory. Strain PCV2/LG was kept in this
laboratory and was selected as the control in this
study.
Virus isolation
Samples from clinical collected materials with PMWS
case were determined by PCR for PCV2. To isolate the
viruses, positive samples were freeze-thawed three
cycles, fragmented and centrifuged. Filtered supernatants
were inoculated onto PK15 cells, free of PCV1 contami-
nation. The PK15 cells were maintained at 37°C with 5%
CO2 in minimum essential medium (MEM) (Invitrogen)
and 5% heat-inactivated FBS (Invitrogen). PCV2 was iso-
lated from the culture supernatants and the isolates
were then detected by PCR and an immunoperoxidase
monolayer assay (IPMA) to confirm the presence of
PCV2.
Genomic amplification for the four isolated viruses by
PCR
To isolate PCV2 DNA, viral isolates were freeze-thawed
three times and then centrifuged. The supernatant was
then used as a template for PCR amplification of the
four isolated PCV2 genomes. The purified PCV2 geno-
mic DNA was PCR amplified using the primer pairs:
PCV2-F1 (920-946 nt; 5’-GTCGACGGAGGAAG
GGGGCCAGTT-3’) and PCV2-R1 (925-901 nt;
5’-GTCGACTGTTCTGTAGCATTCTTCCA-3’). Each
primer was modified by two nucleotides to create a Sal
I restriction enzyme site as a tractable marker (two
modifications of A to G and C to G at the genomic
positions 920 nt and 924 nt, respectively, underlined).
PCR reactions (25 μl) contained 5 μlo fK O DD N A
polymerase reaction buffer (Toyobo, Osaka, Japan), 0.1
mM of each deoxynucleoside triphosphate, 0.4 μMo f
each primer, 1 μl (1 unit) of KOD-Plus-Ver.2 high fide-
lity DNA polymerase (Toyobo) and 100 ng of purified
DNA. PCR was performed on a thermocycler under the
following conditions: 5 min at 94°C, followed by 35
cycles of 30 s at 94°C, 30 s at 61°C and 2 min at 72°C,
and a final step of 10 min at 72°C.
Construction of recombinant plasmid including the
genome of the isolates
PCR amplification of PCV2 genome was performed as
previously described. Amplicon products were purified
using the QIAquick PCR purification kit (Qiagen, Hil-
den, Germany), following the manufacturer’si n s t r u c -
tions. Prior to cloning of the purified DNA fragment, an
A tail was added to the 3’ terminus of the amplicon by
incubation of 12.5 μl of Premix Taq Hot start version
mixture (Takara, Dalian, China) with 12.5 μl of purified
PCR product at 72°C for 30 min. The amplicon with an
A tail was then purified using the QIAquick PCR purifi-
cation kit, cloned into the pMD18 T vector system
(Takara, Dalian, China) and transformed into E. coli
TOP10 competent cells. The resulting colonies were
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Positive colonies were detected by PCR described above,
except that the first denaturation step was performed at
94°C for 10 min. Plasmid DNA was extracted using the
Axygen Plasmid Miniprep Kit (Axygen, Hangzhou,
China) according to the manufacturers’ instructions and
recombinant plasmids were identified by restriction
enzyme analysis with Sal I. Positive plasmids from ten
different colonies per strain were selected for sequen-
cing by the commercial facility (Sangon, Shanghai,
China), and both strands of the insert were sequenced
at least twice, using the M13 universal primers. The
sequences of the DNA fragments were then assembled
using DNAMAN software (Version 5.2.2, Lynnon Bio-
soft, 1994).
Constructions of infectious clone and cell transfection
To obtain an infectious DNA clone of the virus, four
bacteria containing confirmed positive recombinant
plasmids (pMD18-PCV2/CL, JF, YJ and BDH) were sha-
ken for large culture after sequence verification, respec-
tively. The recombinant plasmids were extracted using
the QIAGEN Plasmid Midi Kit (Qiagen, Hilden, Ger-
many) based on the manufacturers’ instructions. The
genomic DNA was separated from the plasmid DNA
after digestion with Sal I by electrophoresis on 1% agar-
ose gels. Viral genomes were extracted using the Axygen
DNA Gel Extraction Kit (Axygen, Hangzhou, China)
according to the manufacturers’ instructions and self-
ligation was performed with T4 DNA ligase (Takara,
Dalian, China) at 16°C for 30 min. PK15 cells were
seeded into six-well tissue culture plates (1 × 10
5 cells/
well) and grown to approximately 60%-80% confluency.
After one wash with OptiMEM medium (Gibco BRL,
Grand Island, USA), cells were transfected with 1.2 μlo f
ligation DNA using Lipofectamine 2000 (Invitrogen,
Carlsbad, USA) according to the manufacturers’ proto-
col. The cells were then overlaid with complete medium
after 6 hours (h) post transfection.
Recovery of the rescued viruses and antigenic
identification
Viruses with tractable genetic marker were recovered
from the transfected cells for serial passage as described
previously [22]. The antigenicity of rescued viruses at
the fourth passage was detected 72 h by IPMA as
described [23]. IPMA was used to detect antigenic activ-
ity of PCV2 positive serum to the rescued PCV2 from
the fourth passage. Briefly, 96-well plates containing the
rescued PCV2, PCV2/LG positive-infected and mock-
infected cells as controls were fixed in 33% acetone-PBS
for 20 min at room temperature and dried. PCV2 posi-
tive serum was added to rescued PCV2, PCV2/LG posi-
tive-infected and mock-infected cells, respectively, and
then incubated at 37°C for 1h. After the unbound anti-
bodies were washed three times with PBS, a 1:3,000
dilution of HRP- conjugated Protein A (Invitrogen,
Carlsbad, USA) was added and the samples were incu-
bated for 1h at 37°C. After washing, color development
was carried out with 3-amino-9-ethylcarbazole and
hydrogen peroxide in 0.05M acetate buffer (pH5.0) for
30 min at 37°C. The reaction was terminated by removal
of the substrate. The plates were examined under an
inverted light microscope. The IPMA was performed in
triplicate.
Genomic DNA cloning and sequencing of rescued viruses
The four full-length PCV2 PCR products amplified from
the DNA extracted from the rescued cells were inserted
into the pMD18-T vector as the method described
above. Positive plasmids from ten different colonies per
strain were selected for sequencing by the commercial
facility (Sangon, Shanghai, China), and both strands of
the insert were sequenced at least twice, using the M13
universal primers as mentioned above. The sequences of
the DNA fragments were then assembled using DNA-
MAN software (Version 5.2.2).
Differentiation of rescued viruses with tractable marker
from wild-type
A pair of primers was designed to amplify the fragment
of both sides of Sal I sites. The forward primer PCV2-
F2 (56-80 nt): 5’-CAGCAAGAAGAATGGAAGA
AGCGGA-3’ and the reverse primer PCV2-R2 (1112-
1088 nt): 5’-CCAGGACTACAATATCCGTGTAACT-3’
were used for PCR amplification, which generated a
fragment of 1057 bp using either the tractable marker
viruses or wild-type viruses DNA as template. PCR pro-
ducts from the rescued viruses with tractable marker
were digested with Sal I to generate two fragments of
865 and 192 bp. PCR products from the wild-type
viruses could not be digested with Sal I, thus remaining
as 1057 bp fragments.
Morphological observations of the rescued viruses
The virus cultures were mixed with a 1:100 dilution of
PCV2-specific antibodies for incubation overnight at 4°
C, and then centrifuged at 14,000 ×g for 30 min. The
immune complexes containing viral particles were har-
vested and morphological characteristics of the virus
were observed using electron microscopy.
PCR-RFLP analysis of rescued virus
PCR was performed as described above and PCR pro-
ducts were digested with 1 U of the restriction enzymes
Fba Ia n dAcc I (Takara, Dalian, China), in a volume of
30 μl for 4 h at 37°C. The digestion products were then
separated by electrophoresis on 1% agarose gel.
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passages
The viral cultures of different passages were serially
diluted 10-fold in MEM medium supplemented with 2%
FBS and antibiotics. Each rescued virus dilution was
inoculated into four separate wells containing 100 μl
PK15 cells in suspension. Virus titers in cell cultures for
each passage were determined by a microtitration infec-
tivity assay and recorded as TCID50 /ml by using the
Reed-Muench method. Briefly, cells were prepared in
96-well plates and inoculated with virus suspensions
(100 μl/well), which were prepared by serial 10-fold
dilution. After absorption for 1 h at 37°C, the liquids in
the wells were removed, and MEM with 2% FBS was
added to the wells. Plates were incubated for an addi-
tional 72 h at 37°C. After the media were removed, the
cells were fixed with a 33% acetone-PBS solution for 20
min at room temperature and air-dried. Virus titers
were determined by the presence of a visible positive
cell by the IPMA method using PCV2-specific antibo-
dies as previously described [23].
Kinetics of the rescued viruses
The rescued viruses from the 10
th passage were inocu-
lated into the six-well tissue culture plates with PK15
cells suspension and a mock-infected cell well was used
as a control. After inoculation at 0 h, 12 h, 24 h, 48 h,
60 h, 72 h, 84 h and 96 h, the cells for each rescued
PCV2 were fixed with a 33% acetone-PBS solution for
20 min at room temperature and air-dried, respectively.
Then, the characteristics of multiplication for the res-
cued viruses were evaluated as the IPMA method pre-
viously described [23].
Antigenic analysis of the four rescued viruses by capture
ELISA using mAb 1D2
MAb 1D2 against PCV2 Cap protein has been prepared
as previously described [23]. The mAb 1D2 is against a
conformational epitope and demonstrates neutralization
activity to PCV2 by a neutralization test (data not
shown). For the antigen capture ELISA, 96-well microti-
ter plates were coated with swine anti-PCV2 positive
sera (1:100 dilution) in 0.1 M carbonate buffer (pH 9.6)
at 4°C overnight, and were then blocked with 5%
skimmed milk for 3 h. After blocking, the plates were
washed three times with PBST (PBS with 0.1% Tween
20). In the binding assay, plates were incubated with the
culture supernatant of the four rescued viruses
(10
4.5TCID50/ml), respectively, at 37°C for 1 h, followed
by three washes with PBST. Bound rescued viruses were
detected with horseradish peroxidase (HRP)-coupled
1D2 mAb against PCV2 Cap. Then, 100 μl of 2,2’-azino-
bis(3-ethylbenzthiazoline-6-sulphonic acid (ABTS) was
added and after 30 min the reaction was stopped with 2
MH 2SO4 and the absorbance at 405 nm was measured
using an ELISA plate reader (Bio-Rad, Hercules, CA,
USA).
Results
Characteristic of the cell isolates from different genotypes
Four representative strains were isolated from clinical
collected materials with multisystemic lesions and clini-
cal signs of PMWS following the verification of nucleic
acid sequencing, an antigen-based IPMA as well as
immune electron (data not shown). The genotypes of
the genomic sequences of the four isolated strains were
designated according to the method of Grau et al. [12].
PCV2/CL strain belonged to the PCV2a genotype;
PCV2/YJ, PCV2/JF strains belonged to the PCV2b geno-
type and PCV2/BDH strain belonged to another new
genotype named as PCV2d [7]. The four representative
strains were named as PCV2a/CL, PCV2b/JF, PCV2b/YJ
and PCV2d/BDH according to the genotype nomencla-
ture. The four sequences were submitted to the Gen-
Bank database and assigned accession numbers
HM038034, HM038022, HM038032 and HM038017,
respectively. The schematic diagram for the four repre-
sentative strains of PCV2 different genotypes is illu-
strated in Figure 1.
Obtaining of PCV2 infectious clone
The infectious clone was obtained through the self liga-
tion of the genomic DNA followed digestion of recom-
binant plasmid by Sal I, gel extraction and ligation at
the created Sal I site by T4 DNA ligase. PK15 Cells
were transfected with 0.8 μg of self ligation DNA using
Lipofectamine 2000 (Invitrogen) according to the manu-
facturer’s protocol.
Identification of the rescued viruses
PK15 cells were transfected with the infectious clone of
the virus and four viruses named PCV2a/rCL, PCV2b/
rJF, PCV2b/rYJ and PCV2d/rBDH as representatives of
different genotypes were successfully rescued by infec-
tious clones after transfections following the identifica-
tion of sequencing, serological detection (Figure 2).
Based on the sequencing, the cloned viruses were com-
pletely the same as the parental strains in nucleic acid
sequence. Viral antigens were detected by IPMA using
PCV2-specific serum. As shown in Figure 2, the virus-
infected cells stained brownish-red, while control cells
transfected in parallel as the mock control showed no
staining. The results revealed the presence of recovered
PCV2 as determined by serology.
Sequencing of the rescued viruses
The four full-length PCV2 PCR products amplified
from the DNA extracted from the rescued cells were
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described above. Two bands of the expected sizes were
obtained for each strain, indicating that the genomes
of the four rescued PCV2 strains had been successfully
cloned into the vectors. The four sequences of the
cloned viruses were exactly the same as the parental
viruses, respectively. Based on the analysis of the four
ORF2-encoded Cap protein sequences, important
mutations located in the C terminus of the Cap
protein are indicated by the red circle in Figure 3.
PCV2b/rYJ showed an elongation of two amino acids
(Asn and Glu), and PCV2d/rBDH showed an elonga-
tion of one amino acid (Lys), compared with the
PCV2a/rCL isolations. Analysis of the ORF2 gene in
the four rescued strains indicated a one-base deletion
at position 1039 in the genome of strain PCV2b/rYJ
(Figure 4), resulting in an ORF2 gene of 708 nt. While
for PCV2d/rBDH, a stop codon mutation in the ORF2
Figure 1 The schematic diagram of PCV2 strains of different genotypes in detail. Analysis of the ORF2 gene in PCV2b/YJ indicated a one-
base deletion at position 1039 in the genome, resulting in an ORF2 gene of 708 nt. For PCV2d/BDH strain, a shift from TTA to CTT in the
genomic sequence resulted in the stop codon mutation (from UAA to AAG) in the ORF2 (at the anti-sense chain of the genomic sequence of
PCV2), being an ORF2 gene of 705 nt in another stop codon.
Figure 2 Identification of four cloned strains of different PCV2 genotypes (PCV2a/rCL, PCV2b/rJF, PCV2b/rYJ and PCV2d/rBDH)
including two new emerging mutants by IPMA. Each of the four rescued strains reacted with swine anti-PCV2 positive sera. PCV2/LG strain
was included as a positive control and PK15 cells were used as negative control.
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gene was elongated by one or two codons due to the
deletion and mutation mentioned above. The basic
characteristics for the rescued viruses are referred to
in Table 1.
Differentiation of rescued viruses with tractable marker
from wild-type parental viruses
The rescued viruses with tractable marker and their paren-
tal wild-type viruses were differentiated by Sal I digestion of
PCR products from amplification of differentiation primers.
Figure 3 Sequence alignment of the deduced amino acid (aa) sequences of the capsid proteins (encoded by ORF2) of the four cloned
strains of PCV2. Mutations at the C terminus of the capsid protein in the four rescued viruses are shown, resulting in elongation of the ORF2
by one lysine residue (for PCV2d/rBDH) or asparagine and glutamic acid residue (for PCV2b/rYJ), compared with the wild-type sequence (red
box).
Figure 4 Analysis of the precise site changes contributed to mutations of Cap protein in the corresponding position in the genome
level. Based on sequencing results of the four rescued PCV2, PCV2b/rYJ showed, and PCV2d/rBDH showed an elongation of one amino acid
(Lys) compared with the PCV2a/rCL isolations. Analysis of the genomic sequencing in the four rescued strains indicated that a one-base deletion
at position 1039 in the genome of strain PCV2b/rYJ (refer to the red arrow) resulted in an elongation of two amino acids (Asn and Glu) in ORF-
encoded Cap protein and a codon mutation from TTA to CTT (marked in black dash box) in the genomic level of PCV2d/rBDH led to the stop
codon mutation from UAA to AAG, being in an amino acid elongation by the next stop codon UGA (reverse complement of TCA, marked in
black box), compared with that of the PCV2a/rCL. Black arrow and black box represent ORF2 translation and ORF2 stop codons of the four
rescued viruses, respectively.
Guo et al. Virology Journal 2011, 8:291
http://www.virologyj.com/content/8/1/291
Page 6 of 10T h es i z eo ft h eP C Rp r o d u c t sa m p l i f i e du s i n gp r i m e r s
PCV2-F56 and PCV2-R1112 were 1057 bp, with no Sal I
site in the parental wild-type viruses. The genomes of the
rescued viruses with tractable marker contained the Sal I
site, and could therefore be digested into two fragments of
865 and 192 bp (Figure 5). Therefore, the rescued viruses
with tractable marker could be differentiated from the par-
ental wild-type viruses by the method mentioned above.
Morphological observations by electron microscopy
The individual cloned virus particle had an approximate
diameter of 17 nm, as determined by electron micro-
scope examination (Figure 6).
Characterization of the rescued viruses by PCR-RFLP
Genomic PCR amplification products from the four iso-
lated PCV2 rescued strains were characterized by
digestion with restriction enzymes Fba Ia n dAcc I, and
analysis of the resulting electrophoresis patterns. The
four cloned viruses were differentiated from each other
by digestion with the restriction enzyme Fba I and Acc I
(Figure 7). The results indic a t e dt h a td i f f e r e n c e si n
nucleic acid level existed among the four rescued viruses
of different genotypes and an effective and simple
method could be established to differentiate the four
rescued PCV2 of different genotypes via PCR-RFLP
using two restriction enzymes.
Viral titration for serial passages
The rescued viruses were continuously cultivated in
PK15 cells for 10 passages. The virus titer increased
with the number of passages. The virus titers strikingly
increased during the second passage and reached up to
10
5.7 TCID50/ml at the 10
th passage (Figure 8). The Sal
I site as the genetic marker in the genome of the res-
cued viruses was stable after 10-serial passages in vitro.
Kinetics of the rescued viruses
Based on the studies of the Kinetics on cell culture of the
rescued viruses, the result indicated that positive-infected
cells first occurred at 24 h post inoculation followed by a
peak time of positive-infected cells at 72 h post inocula-
tion. 72 h later, plasmatorrhexis was present because of
the large propagation of viruses, which led to dissemi-
nated distribution of the positive-infected cells (Figure 9).
Differences in antigen among the four rescued viruses
Antigen capture ELISA using mAb 1D2 showed that
only PCV2a/rCL and PCV2b/rJF rescued virus had
Table 1 Characteristic of rescued viruses including two
mutation strains from different genotypes









GenBank No HM038033 HM038022 HM038032 HM038017
Genotype PCV2a PCV2b PCV2b PCV2d
Year of isolation 2008 2008 2008 2008
Genome length (nt) 1768 1767 1766 1767
ORF2 length (nt) 702 702 708 705
ORF1 length (nt) 945 945 945 945
Number of amino
acid*
0 0 2 (N and E) 1 (K)
Note: * represent the elongation number of amino acid encoded by ORF2
compared with classical PCV2 strains with 233 aa in ORF2-encoded Cap protein.
Figure 6 Immune electron micrograph of negatively stained
rescued PCV2 particles (bar = 20nm). The diameter of particles
was about 17 nm corresponding to the size reported formerly.
Figure 5 Differentiation of the rescued viruses with tractable
marker from their parental wild-type viruses. Sal I digestion of
PCR products of rescued viruses with tractable marker generated
two fragments of 865 and 192 bp; Sal I digestion of PCR products
of parental wild-type viruses generated only one fragment of 1057
bp. The names of the rescued viruses and parental wild-type viruses
are indicated at the corresponding lane above the figure.
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cued viruses (PCV2b/rYJ and PCV2d/rBDH) did not.
The result indicated that mutation of the ORF2 gene
resulted in antigenic changes within the PCV2 Cap pro-
tein for another three cloned viruses (Figure 10).
Discussion
PCV2 has been recognized as the primary causative
agent of PMWS, an economically harmful wasting dis-
ease of young pigs [24]. Disease caused by PCV2 infec-
tion has increased in severity in China in recent years,
resulting in increased morbidity and mortality in swine
and significant economic losses in the swine industry
[7]. More and more studies on the genetic variation
about PCV2 have been increasingly reported at home
and abroad in recent years and some new emerging
PCV2 mutants with one or two amino acids elongation
in ORF2-encoded capsid protein compared with that of
the ordinary PCV2 were already present in clinical
swine farms suffering from PCV2 infection [18]. In this
study, four rescued PCV2 strains were constructed as
representatives prevailing in China corresponding to the
Figure 7 PCR-RFLP profiles of the amplified rescued PCV2 genomic DNA after digestion with restriction enzyme of Fba I (A) and Acc I
(B). Rescued names are indicated above the corresponding lanes. Panel A shows the Fba I digest of the PCR amplification fragments and
restriction fragments are evident at 1165 and 602 bp for PCV2b/rJF, the DNA of other rescued strains (PCV2a/rCL, PCV2b/rYJ and PCV2d/rBDH)
remains undigested. Panel B shows the Acc I digest of the PCR amplification fragments and restriction fragments are evident at 1257 and 511 bp
for PCV2a/rCL; 1532 and 235 bp for PCV2d/rBDH; and 1021 511 and 235 bp for PCV2b/rJF and PCV2b/rYJ. The four rescued strains of different
genotypes as well as mutation rescued viruses can be differentiated by the method via combination use of Fba I and Acc I.
Figure 8 Growth curves of the cloned virus strains after a
series of passages. The virus titers increased with the number of
passages. The virus titers strikingly increased since the second
passage and reached up to 10
5.7 TCID50/ml at the 10
th passage.
Figure 9 Cell culture kinetics of the rescued viruses in different
time by IPMA. Positive-infected cells first occurred at 24 h PI.
followed by peak time of positive-infected cells at 72 h PI, and then
plasmatorrhexis was present because of the large multiplication of
viruses, which led to disseminated distribution of the positive-
infected cells.
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obtaining the newly emerging PCV2 mutation strains
(PCV2b/rYJ and PCV2d/rBDH) with a Sal I tractable
differentiation marker from wild type parental PCV2 via
infectious molecular clone worldwide, although infec-
tious clone only for common infectious PCV2 has been
already rescued by Fenaux et al. in another different way
[25]. The stability of the rescued mutation PCV2 was
verified by successful 10-serial passages in PK15 cells
followed by IPMA and DNA sequencing conformation
after a series of passage (data not shown). It could be
speculated that the mutants could be the predominant
genotypes that are able to evade the immune defense of
the host, which could cause much more severe diseases
to the swine production industry. Therefore, on the one
hand this study was helpful to compare the pathogeni-
city of different genotypes as well as the mutation
PCV2, and on the another hand it helped facilitate
further studies on the mechanism of pathogenicity for
mutation PCV2.
Pure different genotypes PCV2 together with mutants
were obtained by infectious clones, which avoid the
interference of other viruses as contaminant during ani-
mal experiments. Based on the animal experiments with
pure PCV2 particles, more scientific and reliable results
on the pathogenic differences among the different geno-
types as well as the pathogenic changes resulting from
PCV2 mutations could be illustrated. First constructions
of the PCV2 mutation strains will facilitate the further
investigations on pathogenecity caused by variations as
well as early prevention and control ahead of prevailing
of newly emerging PCV2 with mutation.
Conclusion
Taken together, four rescued PCV2 of different geno-
types including two newly emerging PCV2 mutation
strains were obtained in the study. Two newly emerging
PCV2 with mutation were PCV2b/rYJ(ORF2 = 708 bp)
and a novel genotype PCV2d/rBDH(ORF2 = 705 bp),
respectively. Here is the first report of obtaining newly
emerging mutation PCV2 with an introduction of Sal I
as a tractable marker and confirmation of genetically
stability in serial passages in vitro. In addition, mutation
of the ORF2 gene resulted in antigenic changes within
the PCV2 Cap protein by using the mAb 1D2 in capture
ELISA assay. The results will facilitate further studies on
differences in pathogenicity among different genotypes
PCV2 as well as newly emerging mutation PCV2 pre-
vailing clinically in China.
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